Peroxisome Proliferator-Activated Receptor-Targeted Therapies: Challenges upon Infectious Diseases
- PMID: 36831317
- PMCID: PMC9954612
- DOI: 10.3390/cells12040650
Peroxisome Proliferator-Activated Receptor-Targeted Therapies: Challenges upon Infectious Diseases
Abstract
Peroxisome proliferator-activated receptors (PPARs) α, β, and γ are nuclear receptors that orchestrate the transcriptional regulation of genes involved in a variety of biological responses, such as energy metabolism and homeostasis, regulation of inflammation, cellular development, and differentiation. The many roles played by the PPAR signaling pathways indicate that PPARs may be useful targets for various human diseases, including metabolic and inflammatory conditions and tumors. Accumulating evidence suggests that each PPAR plays prominent but different roles in viral, bacterial, and parasitic infectious disease development. In this review, we discuss recent PPAR research works that are focused on how PPARs control various infections and immune responses. In addition, we describe the current and potential therapeutic uses of PPAR agonists/antagonists in the context of infectious diseases. A more comprehensive understanding of the roles played by PPARs in terms of host-pathogen interactions will yield potential adjunctive personalized therapies employing PPAR-modulating agents.
Keywords: bacteria; infection; parasite; peroxisome proliferator-activated receptor; virus.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
 
              
              
              
              
                
                
                References
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Medical
 
        